Gamezumab
- Generic Name
- Gamezumab
An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease
- First Posted Date
- 2021-01-22
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 25
- Registration Number
- NCT04717830
- Locations
- 🇷🇺
Research Institute of Influenza, Sankt-Peterburg, Russian Federation
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath